Health Alert: Kenya Recalls Batch of ‘Toxic’ Cough Syrup

Kenya’s Pharmacy and Poisons Board (PPB) has taken urgent action to recall a batch of cough syrup suspected to be contaminated with a toxic substance. Following an alert received by the PPB indicating potential fatal consequences from consuming the medicine, the regulatory body swiftly issued a recall notice.

The PPB revealed that the Nigerian food and drug agency had alerted them to the presence of an alarming level of diethylene glycol in a specific batch of Benylin pediatric cough syrup contained in 100-ml bottles. This discovery led to an immediate recall in Nigeria. Diethylene glycol ingestion can result in severe symptoms such as abdominal pain, vomiting, diarrhea, altered mental state, and acute kidney injury.

The recall pertains specifically to Batch No. 329304 of Benylin Pediatric 100ml, which is slated to expire this month. In response, the PPB has instructed all pharmaceutical outlets, healthcare facilities, and healthcare professionals in Kenya to halt the distribution of this batch. Additionally, the PPB has initiated its own investigations into the matter to ascertain the extent of the issue and prevent further harm.

While Johnson & Johnson, the manufacturer of the syrup in South Africa, has not yet issued a statement regarding the recall, the regulatory actions taken by the PPB underscore the paramount importance of ensuring the safety and efficacy of pharmaceutical products. The swift response aims to safeguard public health and prevent any potential harm to consumers.

This incident serves as a reminder of the critical role played by regulatory authorities in monitoring the quality and safety of medicines. It highlights the necessity for robust oversight measures and proactive steps to address any identified risks promptly. Consumers are advised to remain vigilant and adhere to recall notices issued by regulatory bodies to minimize health risks associated with contaminated products.